UK drug reg­u­la­tor to restart in­spec­tions at the end of March with a fo­cus on so­cial dis­tanc­ing

The UK’s Med­i­cines and Health­care prod­ucts Reg­u­la­to­ry Agency (MHRA) said Fri­day that it will restart its on­site in­spec­tions of drug man­u­fac­tur­ing sites on March 29 …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER